Valuation: Optipharm.CO.,LTD

Capitalization 7.58TCr 5.19Cr 4.41Cr 4.04Cr 3.81Cr 7.11Cr 490.18Cr 7.17Cr 48Cr 19Cr 235.45Cr 19Cr 19Cr 812.89Cr P/E ratio 2024
-28.9x
P/E ratio 2025 -30x
Enterprise value 7.65TCr 5.24Cr 4.45Cr 4.07Cr 3.84Cr 7.17Cr 494.52Cr 7.23Cr 48Cr 19Cr 237.54Cr 20Cr 19Cr 820.09Cr EV / Sales 2024
3.31x
EV / Sales 2025 3.38x
Free-Float
58.91%
Yield 2024 *
-
Yield 2025 -
1 day+1.57%
1 week-0.39%
Current month-0.39%
1 month-1.34%
3 months-3.72%
6 months+4.97%
Current year+1.37%
1 week 5,010
Extreme 5010
5,190
1 month 5,010
Extreme 5010
6,030
Current year 4,725
Extreme 4725
6,030
1 year 4,725
Extreme 4725
6,250
3 years 4,400
Extreme 4400
9,680
5 years 4,400
Extreme 4400
17,950
10 years 4,400
Extreme 4400
31,150
Manager TitleAgeSince
Chief Executive Officer 54 01/04/2019
Corporate Officer/Principal 57 24/03/2022
Corporate Officer/Principal 54 -
Director TitleAgeSince
Director/Board Member 54 26/03/2019
Director/Board Member 54 -
Director/Board Member 51 24/03/2021
Change 5d. change 1-year change 3-years change Capi.($)
+1.57%-0.39%-2.64%-37.94% 5.19Cr
-5.13%-27.44%-47.99%-55.26% 3.47TCr
-1.50%+5.06%+97.74%+162.78% 1.18TCr
-2.54%-7.45%+25.51%+50.92% 557.04Cr
-1.65%0.00%+18.27%+19.44% 359.43Cr
+1.48%+3.43%+116.19%+40.11% 242.47Cr
-0.82%-1.45%-20.92%-9.59% 175.88Cr
-7.32%-27.13%+78.02%+184.09% 162.26Cr
+0.28%-0.39%-13.72%-10.57% 119.72Cr
+0.41%-1.99%+8.38%-45.93% 110.67Cr
Average -1.33%-6.04%+25.88%+29.81% 638.63Cr
Weighted average by Cap. -3.44%-15.73%+0.94%+10.51%

Financials

2024 2025
Net sales 1.96TCr 1.34Cr 1.14Cr 1.04Cr 98.62L 1.84Cr 126.91Cr 1.86Cr 12Cr 4.83Cr 61Cr 5.04Cr 4.94Cr 210.46Cr 2.23TCr 1.53Cr 1.3Cr 1.19Cr 1.12Cr 2.09Cr 144.41Cr 2.11Cr 14Cr 5.5Cr 69Cr 5.74Cr 5.62Cr 239.49Cr
Net income -235.66Cr -16.13L -13.7L -12.54L -11.84L -22.08L -15Cr -22.27L -1.49Cr -57.98L -7.32Cr -60.5L -59.23L -25Cr -249.92Cr -17.1L -14.53L -13.3L -12.55L -23.41L -16Cr -23.62L -1.58Cr -61.49L -7.76Cr -64.17L -62.82L -27Cr
Net Debt -322.27Cr -22.05L -18.74L -17.15L -16.18L -30.19L -21Cr -30.46L -2.03Cr -79.29L -10Cr -82.74L -81L -35Cr 67Cr 5L 4L 4L 3L 6L 4.34Cr 6L 42.41L 16.53L 2.09Cr 17.25L 16.89L 7.2Cr
Logo Optipharm.CO.,LTD
Optipharm.CO.,LTD is a Korea-based company mainly engaged in the production and sale of veterinary drugs. The Company operates its business through two segments. The Sale Business segment is involved in the provision of livestock disease appraisal services, animal drug distribution, and the manufacturing and sale of feed additives. The New Business segment is engaged in research and development of heterologous organisms, virus like particle (VLP) vaccines, and human diagnostic kits. Heterogeneous organ products include heterologous skin, xenogeneic islets and xenogeneic corneal products, among others. VLP vaccines include VLP based animal combined vaccines and human papillomavirus (HPV) vaccines for the human body, among others. Human body diagnostic kits include human breast cancer and cervical cancer diagnostic reagents, among others. The Company distributes its products within the domestic market and to overseas markets.
Employees
-
Date Price Change Volume
08/26/08 5,170.00 +1.57% 15,601
07/26/07 5,090.00 -0.39% 30,041
06/26/06 5,110.00 -0.39% 76,269
  1. Stock Market
  2. Equities
  3. A153710 Stock